Atsushi Ogawa

Niigata, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Phase II study of glucarpidase in Japanese patients with delayed methotrexate clearance after high-dose methotrexate therapy

Phase II study of glucarpidase in Japanese patients with delayed methotrexate clearance after high-dose methotrexate therapy

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 07, 2025

Phase 2 multicenter study of pegaspargase in Japanese patients with previously untreated acute lymphoblastic leukemia.

Phase 2 multicenter study of pegaspargase in Japanese patients with previously untreated acute lymphoblastic leukemia.

Journal: International journal of hematology
Published: July 22, 2024

Outcomes in children with first-relapsed acute lymphoblastic leukemia in Japan: Results from JCCG Study JPLSG-ALL-R08.

Outcomes in children with first-relapsed acute lymphoblastic leukemia in Japan: Results from JCCG Study JPLSG-ALL-R08.

Journal: Pediatric blood & cancer
Published: April 30, 2024

Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy.

Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy.

Journal: Cancer chemotherapy and pharmacology
Published: December 18, 2023

Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type.

Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type.

Journal: Science advances
Published: December 13, 2023

Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia.

Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia.

Journal: International journal of hematology
Published: January 23, 2023

Three KINSSHIP syndrome patients with mosaic and germline AFF3 variants.

Three KINSSHIP syndrome patients with mosaic and germline AFF3 variants.

Journal: Clinical genetics
Published: November 11, 2022

Development of a population pharmacokinetics and pharmacodynamics model of glucarpidase rescue treatment after high-dose methotrexate therapy.

Development of a population pharmacokinetics and pharmacodynamics model of glucarpidase rescue treatment after high-dose methotrexate therapy.

Journal: Frontiers in oncology
Published: July 26, 2022

Clinical and immunophenotypic characteristics of familial leukemia predisposition caused by PAX5 germline variants.

Clinical and immunophenotypic characteristics of familial leukemia predisposition caused by PAX5 germline variants.

Journal: Leukemia
Published: March 01, 2022

Postchemotherapy immune status in infants with acute lymphoblastic leukemia: A report from the JPLSG MLL-10 trial.

Postchemotherapy immune status in infants with acute lymphoblastic leukemia: A report from the JPLSG MLL-10 trial.

Journal: Pediatric blood & cancer
Published: January 21, 2022

First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors.

First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors.

Journal: Cancer
Published: October 26, 2021

Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan.

Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan.

Journal: Bone marrow transplantation
Published: July 15, 2020
Showing 1-12 of 32

Last Updated: 09/26/2026